Arcus Biosciences, Inc. Gains 17.96%
Thu, Nov 18, 2021 at 05:30 PM
Arcus Biosciences, Inc. (RCUS:NYSE) jumped higher at $43.54, representing a gain of 18%. The stock got featured on our News Catalysts scanner on Thu, Nov 18, 2021 at 03:56 PM in the 'BIOTECH' category. From Wed, Nov 03, 2021, the stock recorded 30.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Arcus Biosciences, Inc. (RCUS:NYSE)
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on developing and commercializing cancer immunotherapies.
Top 10 Gainers:
- LGVN (LGVN:NASDAQ), 135.27%
- Dicerna Pharmaceuticals, Inc. (DRNA:NASDAQ), 78.71%
- Sirius International Insurance Group, Ltd. (SG:NASDAQ), 76.79%
- VOSO (VOSO:NASDAQ), 43.95%
- ClearSign Technologies Corporation (CLIR:NASDAQ), 36.09%
- JWEL (JWEL:NASDAQ), 25.75%
- Macy's, Inc. (M:NYSE), 21.17%
- BJ's Wholesale Club Holdings, Inc. (BJ:NYSE), 19.94%
- CRDF (CRDF:NASDAQ), 18.74%
- Arcus Biosciences, Inc. (RCUS:NYSE), 17.96%